Why the study?
The molecular mechanism by which auxiliary CaV beta subunits control the PIP2 sensitivity of high-voltage-activated Ca2+ channels was unclear.
The anchoring properties of CaV β2 subunits to the plasma membrane determine the biophysical states of CaV2.2 channels by regulating PIP2 coupling to the nonspecific phospholipid-binding site in the I–II loop.
Should not yet change practice around neuronal CaV2.2 modulation; leaves open confirmation of dual PIP2 sites in native cells.
High-voltage-activated Ca 2+ (Ca V ) channels that adjust Ca 2+ influx upon membrane depolarization are differentially regulated by phosphatidylinositol 4,5-bisphosphate (PIP 2 ) in an auxiliary Ca V β subunit-dependent manner. However, the molecular mechanism by which the β subunits control the PIP 2 sensitivity of Ca V channels remains unclear. By engineering various α1B and β constructs in tsA-201 cells, we reported that at least two PIP 2 -binding sites, including the polybasic residues at the C-terminal end of I–II loop and the binding pocket in S4 II domain, exist in the Ca V 2.2 channels. Moreover, they were distinctly engaged in the regulation of channel gating depending on the coupled Ca V β2 subunits. The membrane-anchored β subunit abolished the PIP 2 interaction of the phospholipid-binding site in the I–II loop, leading to lower PIP 2 sensitivity of Ca V 2.2 channels. By contrast, PIP 2 interacted with the basic residues in the S4 II domain of Ca V 2.2 channels regardless of β2 isotype. Our data demonstrated that the anchoring properties of Ca V β2 subunits to the plasma membrane determine the biophysical states of Ca V 2.2 channels by regulating PIP 2 coupling to the nonspecific phospholipid-binding site in the I–II loop.
No takes yet. Share an insight, caveat, or question.
Park et al. (2022) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: